2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …
…, R Gopinathannair, B Gorenek, PL Hess… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Early management of atrial fibrillation to prevent cardiovascular complications
…, JM Conroy, SM Al-Khatib, PL Hess… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) is generally considered a progressive disease, typically evolving from
paroxysmal through persistent to ‘permanent’ forms, a process attributed to electrical and …
paroxysmal through persistent to ‘permanent’ forms, a process attributed to electrical and …
[HTML][HTML] Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
…, LN Marzec, FA Masoudi, PL Hess… - BMC cardiovascular …, 2017 - Springer
Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …
Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate …
…, HM Gilmartin, JW Frank, PL Hess… - Translational …, 2019 - academic.oup.com
There is consensus in dissemination and implementation (D&I) science that addressing
contextual factors is critically important for understanding translation of health care delivery …
contextual factors is critically important for understanding translation of health care delivery …
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation
JM Dizon, TM Nazif, PL Hess, A Biviano, H Garan… - Heart, 2015 - heart.bmj.com
Objective Many patients undergoing transcatheter aortic valve implantation (TAVI) have a
pre-existing, permanent pacemaker (PPM) or receive one as a consequence of the procedure. …
pre-existing, permanent pacemaker (PPM) or receive one as a consequence of the procedure. …
Barbershops as hypertension detection, referral, and follow-up centers for black men
PL Hess, JS Reingold, J Jones, MA Fellman… - …, 2007 - Am Heart Assoc
Barbershops constitute potential sites for community health promotion programs targeting
hypertension (HTN) in black men, but such programs have not been evaluated previously. …
hypertension (HTN) in black men, but such programs have not been evaluated previously. …
[HTML][HTML] Systematic, multimethod assessment of adaptations across four diverse health systems interventions
Background Many health outcomes and implementation science studies have demonstrated
the importance of tailoring evidence-based care interventions to local context to improve fit. …
the importance of tailoring evidence-based care interventions to local context to improve fit. …
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials
…, AH Kadish, PJ Kudenchuk, DB Mark, PL Hess… - American journal of …, 2014 - Elsevier
… Steinman AB 3 , Paul Dorian MD 6 , Al Hallstrom PhD 2 , Riccardo Cappato MD 7 , Alan H.
Kadish MD 8 , Peter J. Kudenchuk MD 2 , Daniel B. Mark MD, MPH 1 , Paul L. Hess MD 1 , …
Kadish MD 8 , Peter J. Kudenchuk MD 2 , Daniel B. Mark MD, MPH 1 , Paul L. Hess MD 1 , …
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials
PL Hess, SM Al-Khatib, JY Han… - … Quality and Outcomes, 2015 - Am Heart Assoc
Background— The impact of patient age on the risks of death or rehospitalization after primary
prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods …
prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods …
Sex and race/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with …
PL Hess, AF Hernandez, DL Bhatt, AS Hellkamp… - Circulation, 2016 - Am Heart Assoc
Background: Previous studies have found that women and black patients eligible for a primary
prevention implantable cardioverter-defibrillator (ICD) are less likely than men or white …
prevention implantable cardioverter-defibrillator (ICD) are less likely than men or white …